Skip to main content

Peer Review reports

From: A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Original Submission
22 Jul 2019 Submitted Original manuscript
25 Aug 2019 Author responded Author comments - Carole Mercier
Resubmission - Version 2
25 Aug 2019 Submitted Manuscript version 2
26 Aug 2019 Editorially accepted
4 Sep 2019 Article published 10.1186/s12885-019-6097-z

You can find further information about peer review here.

Back to article page